Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
News 15 Sep 2026 New DNDi report: Implementing Article 9.5 of the WHO Pandemic Agreement – building on current policy and practice for publicly funded R&D
In the media 9 Sep 2026 Des acteurs pharmaceutiques à but non lucratif s’allient pour faire face à la baisse des financements Swissinfo
Scientific articles 15 Aug 2026 Identification of new Trypanosoma cruzi-specific protein synthesis inhibitors by using a developed high-throughput in vitro translation assay International Journal for Parasitology: Drugs and Drug Resistance
Scientific articles 5 Aug 2026 ICH E21: from landmark guidance to specific action for maternal and child health
Scientific articles 3 Aug 2026 A Phase IIa, Proof-of-Concept, Placebo-Controlled, Randomised Trial to Investigate the Efficacy and Safety of Oxfendazole as a Macrofilaricidal Drug in Adults Harbouring Lymphatic Filarial Worms Infectious Diseases and Therapy
News 30 Nov 2016 Colombia has new diagnostic algorithm for the Chagas Disease Implementation Pilot Projects
News 6 Jun 2016 Ensuring sustained incentives for pharmaceutical companies to develop medicine for the poor
News 27 May 2016 DNDi delivers statement about CEWG on R&D Financing and Coordination at 69th World Health Assembly
News 13 Apr 2016 Hepatitis C: Current barriers to treat patients and DNDi’s R&D strategy to address urgent needs
News 31 Mar 2016 GHIT invests in GeneDesign and DNDi partnership to develop a better treatment for cutaneous leishmaniasis
News 4 Mar 2016 World Lymphedema Day Designated by US Senate: Will Raise Awareness of 40 Million Suffering from Elephantiasis
News 24 Feb 2016 Portfolio Development: New diseases and new chemical entity enter DNDi project portfolio
